Schonfeld Strategic Advisors LLC Athira Pharma, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.76 - $3.71 $19,872 - $26,712	-7,200 Reduced 25.53%	21,000 $66,000
Q3 2022 Nov 14, 2022	BUY	$2.93 - $3.96 $82,626 - $111,672	28,200 New	28,200 $83,000
Q4 2020 Feb 16, 2021	SELL	$16.48 - $34.3 $202,209 - $420,860	-12,270 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $196,565 - $226,504	12,270 New	12,270 $227,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.